Latest stories

  • in

    Immunotherapy response in advanced melanoma influenced by prior treatments: Study

    Immunotherapy response in advanced melanoma influenced by prior treatments: Study

    When a patient is diagnosed with advanced melanoma, they usually are treated with immune therapies like anti-PD-1 blockade and anti-CTLA-4 blockade, in combination or alone. By blocking different proteins that diminish the effectiveness of T cells, these checkpoint inhibitors enhance the body’s immune response to cancer. Research led by scientists at UCLA Jonsson Comprehensive Cancer […] More